Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.

Protein kinases are involved in many essential cellular processes and their deregulation can lead to a variety of diseases, including cancer. The pharmaceutical industry has invested heavily in the identification of kinase inhibitors to modulate these disease-promoting pathways, resulting in several...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Cowan-Jacob, S, Jahnke, W, Knapp, S
Format: Journal article
Sprog:English
Udgivet: Future Science 2014
_version_ 1826258609295589376
author Cowan-Jacob, S
Jahnke, W
Knapp, S
author_facet Cowan-Jacob, S
Jahnke, W
Knapp, S
author_sort Cowan-Jacob, S
collection OXFORD
description Protein kinases are involved in many essential cellular processes and their deregulation can lead to a variety of diseases, including cancer. The pharmaceutical industry has invested heavily in the identification of kinase inhibitors to modulate these disease-promoting pathways, resulting in several successful drugs. However, the field is challenging as it is difficult to identify novel selective inhibitors with good pharmacokinetic/pharmacodynamic properties. In addition, resistance to kinase inhibitor treatment frequently arises. The identification of non-ATP site targeting ('allosteric') inhibitors, the identification of kinase activators and the expansion of kinase target space to include the less studied members of the family, including atypical- and pseudo-kinases, are potential avenues to overcome these challenges. In this perspective, the opportunities and challenges of following these approaches and others will be discussed.
first_indexed 2024-03-06T18:36:40Z
format Journal article
id oxford-uuid:0b7ace66-6e5c-4b4e-b8c4-d069c308eb2c
institution University of Oxford
language English
last_indexed 2024-03-06T18:36:40Z
publishDate 2014
publisher Future Science
record_format dspace
spelling oxford-uuid:0b7ace66-6e5c-4b4e-b8c4-d069c308eb2c2022-03-26T09:29:35ZNovel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0b7ace66-6e5c-4b4e-b8c4-d069c308eb2cEnglishSymplectic Elements at OxfordFuture Science2014Cowan-Jacob, SJahnke, WKnapp, SProtein kinases are involved in many essential cellular processes and their deregulation can lead to a variety of diseases, including cancer. The pharmaceutical industry has invested heavily in the identification of kinase inhibitors to modulate these disease-promoting pathways, resulting in several successful drugs. However, the field is challenging as it is difficult to identify novel selective inhibitors with good pharmacokinetic/pharmacodynamic properties. In addition, resistance to kinase inhibitor treatment frequently arises. The identification of non-ATP site targeting ('allosteric') inhibitors, the identification of kinase activators and the expansion of kinase target space to include the less studied members of the family, including atypical- and pseudo-kinases, are potential avenues to overcome these challenges. In this perspective, the opportunities and challenges of following these approaches and others will be discussed.
spellingShingle Cowan-Jacob, S
Jahnke, W
Knapp, S
Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
title Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
title_full Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
title_fullStr Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
title_full_unstemmed Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
title_short Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases.
title_sort novel approaches for targeting kinases allosteric inhibition allosteric activation and pseudokinases
work_keys_str_mv AT cowanjacobs novelapproachesfortargetingkinasesallostericinhibitionallostericactivationandpseudokinases
AT jahnkew novelapproachesfortargetingkinasesallostericinhibitionallostericactivationandpseudokinases
AT knapps novelapproachesfortargetingkinasesallostericinhibitionallostericactivationandpseudokinases